Henri Jullien

Henri Jullien has a diverse work experience in the pharmaceutical industry. Henri recently joined Theratechnologies Inc. as an Associate Medical Director for Europe. Prior to that, they worked as a European Medical Advisor - HIV and Hepatology for Syneos at Theratechnologies Inc., and as a National Medical Science Liaison in France. Before their time at Theratechnologies Inc., Henri worked at Intercept Pharmaceuticals as a Medical Science Liaison specializing in Hepatology. Henri actively participated in the pre-launch and launch of various drugs and was involved in clinical studies and identifying potential study investigators. Henri also gained experience at AbbVie, Novartis Vaccines, AstraZeneca, Merck, Roche, and AFSSAPS (now ANSM), where they held various roles related to medical science liaison, medical advising, and evaluating national drug programs. Throughout their career, Henri has built a network of key opinion leaders, performed presentations, organized professional meetings, and conducted medical educational programs.

Henri Jullien began their education in 2000 and completed a PharmD degree at the Faculty of Pharmacy in Montpellier, France in 2006. In the same year, they also attended the ESCP Business School, where they earned a Master Spécialisé in "Management Médical". Later, in 2011-2012, they pursued further studies at the Faculty of Law, also in Montpellier, and obtained a Master degree in "Droit de la santé et des établissements de santé" with a focus on health law and the law of medical establishments.